Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
BRBruker Corporation logo

Bruker Corporation (BRKR)

NASDAQ Global Select · Currency in USD
$57.59 ▲ +0.28 (+0.49%)
At close: Oct 23, 4:00 PM ET. Market closed.
$57.58 ▼ -0.01 (-0.02%)
After hours: Oct 23, 7:31 PM ET

Summary

Previous Close
$57.31
Open
$56.93
Day's Range
$55.32 – $57.71
52 Week Range
$32.37 – $66.98
Volume
1,219,702
Avg. Volume
2,218,818
Market Cap
$8.77B
Beta (5Y Monthly)
1.22
PE Ratio (TTM)
--
EPS (TTM)
-$0.47
Earnings Date
Nov 4, 2026
Forward Dividend & Yield
$0.20 (0.35%)
Ex-Dividend Date
Sep 21, 2026
1y Target Est
$67.00

Profile: Bruker Corporation

Sector
Healthcare
Industry
Medical - Devices
Full-time employees
11,085
CEO
Frank H. Laukien
Website
bruker.com

Bruker Corporation stands as a prominent global developer, manufacturer, and distributor of cutting-edge scientific instruments, alongside comprehensive analytical and diagnostic solutions. Its operations are structured across three distinct segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. The company's extensive portfolio for life sciences encompasses a variety of advanced tools, including single and multi-modality systems, sophisticated mass spectrometry platforms, and critical diagnostic solutions.

Earnings

Next report: Wed, Nov 4, 2026
EPS estimate $0.42 · Revenue est. $865.16M
DateEst.Actual
Aug 4, 2026$0.38$0.49Beat
May 6, 2026$0.23$0.31Beat
Feb 12, 2026$0.65$0.59Miss
Nov 3, 2025$0.33$0.60Beat
Aug 4, 2025$0.33$0.32Miss
May 7, 2025$0.46$0.47Beat

Analyst view

Consensus price target
$67.00 ▲ +16.3%
Range $50.00 – $80.00
Rating: Buy
Buy 48% · Hold 45% · Sell 6%

Get free alerts on BRKR and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.